November 22, 2016 - By Vivian Park · 0 Comments
Dynatronics Corp (NASDAQ:DYNT) institutional sentiment increased to 4 in Q2 2016. Its up 3.00, from 1 in 2016Q1. The ratio increased, as 2 hedge funds opened new or increased holdings, while 2 sold and reduced their positions in Dynatronics Corp. The hedge funds in our partner’s database now possess: 177,361 shares, up from 177,305 shares in 2016Q1. Also, the number of hedge funds holding Dynatronics Corp in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 1 Increased: 1 New Position: 1.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The company has a market cap of $7.50 million. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. It currently has negative earnings. The Company’s products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
It is down 11.30% since April 20, 2016 and is downtrending. It has underperformed by 15.85% the S&P500.
According to Zacks Investment Research, “DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners.”
Perritt Capital Management Inc holds 0.05% of its portfolio in Dynatronics Corporation for 61,173 shares. Bank Of America Corp De owns 20,007 shares or 0% of their US portfolio. Moreover, Blackrock Institutional Trust Company N.A. has 0% invested in the company for 22,786 shares. The New York-based Citigroup Inc has invested 0% in the stock. Tower Research Capital Llc (Trc), a New York-based fund reported 886 shares.#img1#
Dynatronics Corporation, incorporated on April 29, 1983, is a maker and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. The Company’s products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. The Company’s physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy, ultrasound, phototherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including motorized and stationary treatment tables, parallel bars, traction systems and wood furniture; manufactured supplies, including hot pack and covers, cold packs, braces, belts, wraps, straps, pillow and cushions, wedges, bolsters and mats; distributed capital products, including hydrotherapy, exercise equipment, weight training equipment and pilates, and distributed supplies, including clinical accessories, aids to daily living, exercise balls and bands, sports med and taping products, lotions and gels.
More notable recent Dynatronics Corporation (NASDAQ:DYNT) news were published by: Prnewswire.com which released: “Dynatronics Corporation Names Tyler Oglesby Director of Post-Acute Care Sales …” on January 11, 2016, also Prnewswire.com with their article: “Dynatronics Releases its Latest Stand Alone Ultrasound, the Dynatron® 125B” published on September 20, 2016, Prnewswire.com published: “Dynatronics Strengthens Sales Organization Leadership” on March 02, 2016. More interesting news about Dynatronics Corporation (NASDAQ:DYNT) were released by: Prnewswire.com and their article: “Dynatronics Expands Presence at the University of Utah” published on January 19, 2016 as well as Prnewswire.com‘s news article titled: “Dynatronics Announces Completion Of $4025000 Private Placement Led By …” with publication date: July 01, 2015.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park